Practice habits of Mohs surgeons treating melanoma with Mohs surgery: A cross-sectional survey
نویسندگان
چکیده
To the Editor: Mohs micrographic surgery (MMS) is increasingly used to treat melanoma in United States.1Lee M.P. Sobanko J.F. Shin T.M. et al.Evolution of excisional practices for States.JAMA Dermatol. 2019; 155: 1244-1251Crossref Scopus (10) Google Scholar Recent studies have shown lower recurrence rates and improved survival outcomes treated with MMS compared wide local excision.2Cheraghlou S. Christensen S.R. Agogo G.O. Girardi M. Comparison after vs margin excision early-stage invasive melanoma.JAMA 1252-1259Crossref (12) Scholar,3Hanson J. Demer A. Liszewski W. Foman N. Maher I. Improved overall head neck versus excision.J Am Acad 2020; 82: 149-155Abstract Full Text PDF PubMed (13) Given variations practice patterns combined a lack best guidelines,1Lee this survey surgeons sought elucidate habits by who situ MMS. This study was nationwide cross-sectional membership American College Surgery (ACMS). An anonymous developed distributed all ACMS members (N = 1630) during March 2020 through May using mailing lists. defined as intraoperative frozen section analysis. Excisional en face permanent analysis (“slow Mohs”) not considered Fellowship exposure treating at least 1 case sections fellowship. The inquired about subtypes (primary tumor [T], Joint Committee on Cancer, 8th Edition), anatomic locations treated, number cases per year, processing debulked specimens, initial sizes (the total distance beyond clinically apparent first stage), depth stage, immunohistochemical (IHC) staining. approved institutional review board University Kansas. Chi-square, Fisher exact tests, 1-way variance were compare differences between groups, P < .05 statistically significant. A 1002 participants completed (61.5% response rate; average age, 46 ± 11 years; 632 [64.1%] male; 715 [71.4%] private practice; 174 [17.4%] Midwest, 185 [18.5%] Northeast, 246 [24.6%] Southeast, 131 [13.1%] Southwest, 219 [21.9%] West, 47 [4.7%] other/unspecified location). Half (n 499; 50.0%) received fellowship melanoma. Among 363 (36.2% overall) (MMS-M), 216 (59.5%) (T1) melanoma, 76 (20.9%) (T≥2) (Table I). MMS-M more likely debulk (MIS) (93.2% T≥1 85.4% MIS; .002). MIS, T1, T≥2 melanomas 4.99 mm, 6.60 7.52 respectively (P .001) II). excise down fascia stage MIS (22.6% 3.0% .001). submit an additional layer around negative (16.0% 7.2% melanoma; majority 273; 75.2%) use IHC stains nearly 267; 97.8%) antigen recognized T cells (MART-1) their primary stain.Table IPractice 363)CharacteristicMohs MMS, n (%)Subtypes treated∗Based Edition staging criteria. LM348 (95.9) (subtypes excluding LM)332 (91.5) T1216 (59.5) T2 and/or greater76 (20.9)Anatomic location Head neck360 (99.2) Trunk extremities (excluding hands feet)174 (47.9) Hands, feet, genitalia259 (71.3)Number year ≤40204 (56.2) 41-120118 (32.5) 121-20021 (5.8) >20020 (5.5)IHC staining Yes273 (75.2) No90 (24.8)IHC MART-1261 (95.6) MITF11 (4.0) S-10011 HMB-453 (1.1)IHC, Immunohistochemical; LM, lentigo maligna; situ; surgery.∗ Based Open table new tab Table IIMelanoma surgeryCharacteristicsMohs subtypes∗Based (%)P value†Comparisons groups conducted chi-square, test, variance.MIS 363)T1 216)T≥2 76)Debulk.005 Yes310 (85.4)199 (92.1)73 (96.1) No53 (14.6)17 (7.9)3 (3.9)Debulk technique.94 Debulk scalpel305 (98.4)212 (98.1)76 (100.0) curette5 (1.6)4 (1.9)0 (0.0)Debulked specimen processing.15 Permanent vertical sectioning184 (60.3)126 (59.4)42 (55.3) Frozen sectioning31 (10.3)11 (5.2)3 (3.9) Both87 (28.5)72 (34.0)29 (38.2) Discard3 (0.9)3 (1.4)2 (2.6)Initial margins (debulk + 1st mm<.001 Mean (SD)4.99 (1.66)6.60 (2.69)7.52 (2.24)Depth stage<.001 Deep dermis17 (4.7)3 (2.6) Subcutaneous fat335 (92.3)173 (80.1)48 (63.2) Fascia11 (3.0)40 (18.5)26 (34.2)Additional margin<.001 No305 (84.0)195 (90.3)76 Yes, analysis56 (15.4)13 (6.0)0 (0.0) analysis0 (0.0)0 both frozen2 (0.6)8 (3.7)0 (0.0)MIS, Melanoma surgery; SD, standard deviation.∗ criteria.† Comparisons variance. IHC, surgery. deviation. our knowledge, largest date investigate findings suggest that are early MART-1 In addition, wider when
منابع مشابه
Mohs Micrographic Surgery for Melanoma (printer-friendly)
Mohs chemosurgery, using the fixed-tissue technique, was proposed for the treatment of melanoma by Frederic Mohs in 1950.[1] In numerous publications since, Mohs reported cure rates at least comparable to those obtained with the conventional surgical therapies of the time. Initially, Mohs believed that the in situ tissue fixation with zinc chloride paste inherent in the fixed-tissue technique w...
متن کاملMohs Micrographic Surgery for Melanoma (printer-friendly)
Mohs chemosurgery, using the fixed-tissue technique, was proposed for the treatment of melanoma by Frederic Mohs in 1950.[1] In numerous publications since, Mohs reported cure rates at least comparable to those obtained with the conventional surgical therapies of the time. Initially, Mohs believed that the in situ tissue fixation with zinc chloride paste inherent in the fixed-tissue technique w...
متن کاملMohs micrographic surgery.
Mohs micrographic surgery (MMS) is a specialized type of minimal marginal surgery that offers cure rates superior to other options in the treatment of contiguous skin cancers in selected settings. Developed by Dr. Frederic E. Mohs, the technique originally required in situ tissue fixation before excision. Most Mohs micrographic surgeons now use the fresh tissue technique exclusively. Horizontal...
متن کاملPerioperative management of anticoagulant therapy during cutaneous surgery: 2005 survey of Mohs surgeons.
BACKGROUND The perioperative management of anticoagulation and antiplatelet therapy is a controversial topic in the field of dermatologic surgery. Dermasurgeons must weigh the risk of bleeding against the risk of thrombotic complications when deciding how to manage perioperative anticoagulation. OBJECTIVE Our aim is to present a summary of current practice in anticoagulation management periop...
متن کاملMohs surgery: commentaries and controversies.
There is an enormous amount of literature pertaining to the subject of Mohs surgery, ranging from its various indications to therapeutic results. One constant limiting factor in this body of knowledge, however, is the scarcity of randomized, controlled studies comparing Mohs surgery with other effective therapeutic modalities. Obviously, it is hard to gather solid scientific evidence in favor o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of The American Academy of Dermatology
سال: 2021
ISSN: ['1097-6787', '0190-9622']
DOI: https://doi.org/10.1016/j.jaad.2020.09.081